Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories

(2017) Renea A. Taylor et al.   Nature Communications

Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer

(2015) Elena Castro et al.   EUROPEAN UROLOGY

Clinical Management of Prostate Cancer in Men with BRCA Mutations

(2015) Ola Bratt et al.   EUROPEAN UROLOGY

Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

(2014) Elizabeth K. Bancroft et al.   EUROPEAN UROLOGY

Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond

(2014) Christos Mikropoulos et al.   Future Oncology

PSA velocity: A systematic review of clinical applications

(2014) Kevin Raymond Loughlin   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

The Melbourne Consensus Statement on the early detection of prostate cancer

(2013) Declan G. Murphy et al.   BJU INTERNATIONAL

Screening for Prostate Cancer: Results of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer

(2013) Monique J. Roobol et al.   EUROPEAN UROLOGY

GermlineBRCAMutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer

(2013) Elena Castro et al.   JOURNAL OF CLINICAL ONCOLOGY

The genetic epidemiology of prostate cancer and its clinical implications

(2013) Rosalind Eeles et al.   Nature Reviews Urology

Germline BRCA1 mutations increase prostate cancer risk

(2012) D Leongamornlert et al.   BRITISH JOURNAL OF CANCER

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

(2011) Z Kote-Jarai et al.   BRITISH JOURNAL OF CANCER

Decreased Prostate Cancer-Specific Survival of Men withBRCA2 Mutations from Multiple Breast Cancer Families

(2011) Heather Thorne et al.   Cancer Prevention Research

Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations

(2011) A. Moran et al.   Familial Cancer

An Empirical Evaluation of Guidelines on Prostate-specific Antigen Velocity in Prostate Cancer Detection

(2011) Andrew J. Vickers et al.   JNCI-Journal of the National Cancer Institute

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis

(2010) S M Edwards et al.   BRITISH JOURNAL OF CANCER

Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer

(2010) D. J. Gallagher et al.   CLINICAL CANCER RESEARCH

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype

(2008) A Mitra et al.   BRITISH JOURNAL OF CANCER

Rapid progression of prostate cancer in men with a BRCA2 mutation

(2008) S A Narod et al.   BRITISH JOURNAL OF CANCER